Interventional Cardiology: Implantable Cardioverter Defibrillators
Interventional Cardiology: Implantable Cardioverter Defibrillators
$4,750.00
This comprehensive medical market and technology report provides an overview and in-depth market analysis of implantable cardioverter defibrillators (ICDs) used to treat forms of cardiac arrhythmia and heart failure (HF).
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Key Questions Answered
- What are the key drivers and limiters to the global ICD products market?
- Which competitors are leading the market and introducing new technology?
- How are technological advancements impacting market growth?
- Which areas of the ICD products market are experiencing dynamic growth?
- How are mergers and acquisitions affecting the markets shares of leading competitors?
ICD Highlights
- The most influential driver of the global ICDs market is the increasing prevalence of cardiovascular disease as a result of the expanding geriatric population and an increasing prevalence of CVD risk factors such as obesity and diabetes.
- The combined global market for ICD devices totals nearly $8bn, and is expected to climb at a CAGR of 4.4% through 2023.
- The US and five major EU markets each accounted for more than one-third of global ICD sales in 2018, with the RoW segment accounting for nearly one-quarter of sales and Japan accounting for 6%.
- Current technological trends in the global ICDs market include remote monitoring applications, new algorithms for the discrimination of significant arrhythmias, software to improve battery life, MRI compatibility, and quadripolar leads.
Overview
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable cardioverter defibrillator (ICD) products market. Types of cardiac defibrillators covered by the scope of this report include ICDs, subcutaneous ICDs (S-ICDs), and cardiac resynchronization therapy-defibrillators (CRT-Ds).
The combined global market for ICD devices totals nearly $8bn, and is expected to climb at a CAGR of 4.4% through 2023. The most influential driver of the global ICDs market is the increasing prevalence of cardiovascular disease (CVD) as a result of the expanding geriatric population and an increasing prevalence of CVD risk factors such as obesity and diabetes.
Executive Summary
This comprehensive medical market and technology report provides an overview and in-depth market analysis of implantable cardioverter defibrillators (ICDs) used to treat forms of cardiac arrhythmia and heart failure (HF). Types of cardiac defibrillators covered by the scope of this report include ICDs, subcutaneous ICDs (S-ICDs), and CRT-Ds.
The report provides the following useful information:
- an overview of cardiac rhythm disorders and HF
- key statistics on selected forms of cardiac rhythm disorders and HF in major regions in the world
- medical device product portfolios offered by manufacturers
- insight into developing and potentially disruptive technologies
- in-depth market and competitive analysis
Table of Contents
Executive Summary ………………………………………………………………………. ES-1
i. Cardiac rhythm disorders overview………………………………………………………………………..ES-1
ii. Global implantable cardioverter defibrillator products market …………………………………ES-1
a. Market drivers and limiters……………………………………………………………………….ES-3
b. Device segment insights …………………………………………………………………………..ES-4
c. Technology trends……………………………………………………………………………………ES-5
d. Market leaders………………………………………………………………………………………..ES-5
e. Competitive strategies……………………………………………………………………………..ES-6
f. Emerging competition ………………………………………………………………………………ES-6
iii. Methodology……………………………………………………………………………………………………..ES-7
Exhibit ES-1: Global implantable cardioverter defibrillator products market forecast ($m), 2018-23……………………………………………………………………………………………………..ES-2
Exhibit ES-2: Global implantable cardioverter defibrillator products market, by country/region, 2018 ………………………………………………………………………………ES-3
Exhibit ES-3: Drivers and limiters of growth – implantable cardioverter defibrillator products………………………………………………ES-4
1. Cardiac Rhythm Disorders Overview……………………………………………….1-1
1.1 Sick sinus syndrome…………………………………………………………………………………………… 1-4
1.2 Bradycardia ………………………………………………………………………………………………………. 1-4
1.3 Heart block……………………………………………………………………………………………………….. 1-5
1.4 Tachycardia ………………………………………………………………………………………………………. 1-6
1.5 Atrial fibrillation………………………………………………………………………………………………… 1-7
1.6 Heart failure……………………………………………………………………………………………………… 1-8
1.7 Diagnosis and treatment…………………………………………………………………………………… 1-11
1.8 Bibliography ……………………………………………………………………………………………………. 1-12
Exhibit 1-1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias, based on healthcare utilization, select countries…………………………………………….. 1-2
Exhibit 1-2: Estimated number of hospital discharges for conduction disorders and cardiac arrhythmias, select countries…………………………………………………………….. 1-3
Exhibit 1-3: Estimated prevalence of atrial fibrillation, select countries, 2018………………… 1-8
Exhibit 1-4: Estimated prevalence of chronic heart failure, select countries, 2018………….. 1-9
Exhibit 1-5: Estimated prevalence of acute decompensated heart failure, select countries, 2018………………………………………………………………………………… 1-10
2. Implantable Cardioverter Defibrillator Products ……………………………….2-1
2.1 Implantable cardioverter defibrillator systems……………………………………………………… 2-2
2.1.1 Implantable cardioverter defibrillator products………………………………………. 2-4
2.1.2 Developments in implantable cardioverter defibrillator technology………….. 2-6
2.2 Bibliography ……………………………………………………………………………………………………… 2-9
Exhibit 2-1: Generic NBD codes for implantable cardioverter defibrillators……………………………….. 2-4
Exhibit 2-2: Selected ICDs and manufacturers………………………………………………………………………… 2-5
Exhibit 2-3: Selected CRT-Ds and manufacturers ……………………………………………………………………. 2-6
3. Implantable Cardioverter Defibrillator Products Market…………………….3-1
3.1 Global market insights……………………………………………………………………………………….. 3-1
3.1.1 Market value………………………………………………………………………………………. 3-1
3.1.2 Technology trends ………………………………………………………………………………. 3-5
3.1.3 Market drivers and limiters ………………………………………………………………….. 3-6
3.1.4 ICD products overview…………………………………………………………………………. 3-7
3.1.5 Market leaders……………………………………………………………………………………. 3-9
3.1.6 Competitive strategies…………………………………………………………………………. 3-9
3.1.7 Emerging competition ……………………………………………………………………….. 3-10
3.2 Global competitors ………………………………………………………………………………………….. 3-10
3.3 Market forecast……………………………………………………………………………………………….. 3-12
3.3.1 Market forecast: US …………………………………………………………………………… 3-12
3.3.2 Market forecast: five major EU markets……………………………………………….. 3-16
3.3.3 Market forecast: Japan ………………………………………………………………………. 3-19
3.3.4 Market forecast: rest of the world ………………………………………………………. 3-22
3.4 Bibliography ……………………………………………………………………………………………………. 3-25
Exhibit 3-1: ICD products, global market forecast ($m), 2018-23 ……………………………………………… 3-2
Exhibit 3-2: ICD products, global market forecast ($m), by product type, 2018-23……………………… 3-3
Exhibit 3-3: Global ICD products market, share by country/region, 2018…………………………………… 3-4
Exhibit 3-4: Global ICD product sales, global market forecast ($m), by country/region, 2018-23….. 3-5
Exhibit 3-5: Drivers and limiters of market growth – ICD products……………………………………………. 3-7
Exhibit 3-6: ICD products, global market forecast ($m), by product type, 2018-23……………………… 3-8
Exhibit 3-7: Global ICD products market, share by supplier, 2018…………………………………………… 3-12
Exhibit 3-8: US ICD implantations, procedure volumes forecast (000s), 2018-23………………………. 3-14
Exhibit 3-9: US ICD product sales, market forecast ($m), by product type, 2018-23………………….. 3-15
Exhibit 3-10: 5EU ICD implantations, procedure volumes forecast (000s), 2018-23…………………… 3-17
Exhibit 3-11: 5EU ICD product sales, market forecast ($m), by product type, 2018-23………………. 3-18
Exhibit 3-12: Japanese ICD implantations, procedure volumes forecast (000s), 2018-23 …………… 3-20
Exhibit 3-13: Japanese ICD product sales, market forecast ($m), by product type, 2018-23……….. 3-21
Exhibit 3-14: RoW ICD product sales, market forecast ($m), by product type, 2018-23 …………….. 3-24
Appendix: Company Listing……………………………………………………………… A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Infection Control and Biosafety Products 
Sign up to the